RPRX

Q: What is the price of Royalty Pharma (RPRX) today?

The current price of Royalty Pharma (RPRX) is $ 55.87, representing a 70.15% gain over the past year. The stock began the year trading around $ 38.64 and is currently priced at $ 55.87. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Royalty Pharma (RPRX) pay dividends?

In the last year, Royalty Pharma (RPRX) distributed dividends in the month of March, totaling $ 0.24. The Dividend Yield for the last 12 months is 1.60%.

Royalty Pharma PLC

Price

$ 55.87

return (12m)

70.15%

p/e

29.51

p/bv

2.46

DIVIDEND YIELD

1.60%

RPRX price

Royalty Pharma

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment RPRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

11.29%

3 months

24.28%

1 year

70.15%

2 years

118.74%

5 years

35.96%

10 years

0.00%

Fundamentals RPRX

review the fundamentals of Royalty Pharma shares

P/E

29.51

Sector: -137.58 Industry: 9.50

P/S (PSR)

10.00

Sector: 1.15 Industry: 1.47

P/BV

2.46

Sector: -6.52 Industry: 1.58

DIVIDEND YIELD (DY)

1.60%

Sector: 0.39% Industry: 0.54%

ROA

4.18%

Sector: -1,439.26% Industry: 2.35%

ROE

8.33%

Sector: -2,915.03% Industry: 10.90%

ROIC

13.56%

Sector: -11.66% Industry: -3.35%

NET MARGIN

33.90%

Sector: -0.45% Industry: 8.00%

GROSS MARGIN

100.00%

Sector: -0.53% Industry: 34.09%

OPERATING MARGIN

67.93%

Sector: -5.58% Industry: 6.49%

EV/EBITDA

14.36

Sector: -102.31 Industry: 6.21

EV/EBIT

14.40

Sector: -109.86 Industry: 1.29

PRICE-TO-ASSETS

1.23

Sector: 0.12 Industry: 0.44

BVPS

22.74

Sector: -3,898.98 Industry: 21.73

EPS

1.89

Sector: -9,612.89 Industry: 3.00

EQUITY-TO-ASSETS RATIO

0.50

Sector: 0.00 Industry: 0.22

LIABILITIES / ASSETS

0.50

Sector: 0.32 Industry: 0.68

CAGR REVENUE 5 YEARS

1,124.62%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

1,265.94%

Sector: - Industry: -

FAIR VALUE OF Royalty Pharma ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current Price

$ 55.87

Fair Value

$ 31.10

Upside Return potential.

-44.34%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals RPRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JPM	14.34	2.32	16.18%	1.90%	$ 844.32 B	31.51%
NU	18.46	4.67	25.29%	0.00%	$ 58.78 B	18.15%
MA	28.10	65.09	231.63%	0.66%	$ 437.55 B	45.88%
BAC	12.32	1.30	10.54%	2.04%	$ 390.59 B	27.32%
BRK-B	14.53	1.44	9.94%	0.00%	$ 1.05 T	17.28%
HSBC	14.32	1.62	11.31%	4.02%	$ 319.42 B	32.99%
BRK-A	10.12	1.01	9.94%	0.00%	$ 733.55 B	17.28%
C	14.36	1.08	7.54%	1.81%	$ 230.10 B	18.19%
BLK	24.67	2.44	9.88%	2.15%	$ 154.32 B	24.40%
RY	16.92	2.65	15.67%	2.32%	$ 271.46 B	31.85%
PYPL	7.45	1.88	25.26%	0.68%	$ 37.70 B	15.00%
ING	11.46	1.42	12.43%	4.55%	$ 85.75 B	27.73%
PAGS	859.04	121.29	14.12%	7.27%	$ 2.41 B	11.64%
AXP	19.16	6.27	32.71%	1.10%	$ 213.11 B	13.49%
WFC	11.63	1.40	12.03%	2.20%	$ 252.38 B	25.60%
BBVA	10.01	1.79	17.87%	4.87%	$ 125.74 B	27.30%
XP	8.60	1.78	20.74%	1.13%	$ 8.41 B	28.04%
MS	19.04	2.95	15.51%	1.89%	$ 337.60 B	14.75%
LYG	11.46	1.21	10.59%	3.76%	$ 78.06 B	24.69%
BCS	3.44	0.47	13.64%	1.89%	$ 83.28 B	34.72%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

RPRX Historical Dividends

current DY: 1.60%

5-year average DY: 2.51%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	05/14/2026	06/10/2026	0,24000000
Dividends	02/19/2026	03/10/2026	0,23500000
Dividends	11/13/2025	12/10/2025	0,22000000
Dividends	08/14/2025	09/10/2025	0,22000000
Dividends	05/15/2025	06/10/2025	0,22000000
Dividends	02/20/2025	03/10/2025	0,22000000
Dividends	11/14/2024	12/10/2024	0,21000000
Dividends	08/15/2024	09/13/2024	0,21000000
Dividends	05/15/2024	06/14/2024	0,21000000
Dividends	02/14/2024	03/15/2024	0,21000000
Dividends	11/15/2023	12/15/2023	0,20000000
Dividends	08/16/2023	09/15/2023	0,20000000
Dividends	05/17/2023	06/15/2023	0,20000000
Dividends	02/14/2023	03/15/2023	0,20000000
Dividends	11/16/2022	12/15/2022	0,19000000
Dividends	08/17/2022	09/15/2022	0,19000000
Dividends	05/18/2022	06/15/2022	0,19000000
Dividends	02/16/2022	03/15/2022	0,19000000
Dividends	11/17/2021	12/15/2021	0,17000000
Dividends	08/18/2021	09/15/2021	0,17000000
Dividends	05/18/2021	06/15/2021	0,17000000
Dividends	02/17/2021	03/15/2021	0,17000000
Dividends	11/18/2020	12/15/2020	0,15000000
Dividends	09/11/2020	09/30/2020	0,15000000

ABOUT Royalty Pharma

Royalty Pharma PLC

Average Investor10 user rating

4.0 (2 people)

United States

6 years

Founded: 2020

2020

Time since IPO - 6 years

-

Employees

Royalty Pharma PLC (United States) is listed on the Nasdaq and has a market capitalization of $24.42 Billions, with shareholders equity totaling $9.94 Billions.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Royalty Pharma PLC reported $2.44 Billions in revenue, generating net income of $827.30 Millions.

Key financial metrics include a P/E ratio of 29.51, a price-to-book (P/B) ratio of 2.46, and a trailing twelve-month dividend yield of 1.60%.

The company trades under the ticker RPRX.

Market cap

$ 24.42 Billions

Net worth

$ 9.94 Billions

$ 9,936,830,000.00

Assets

$ 19.82 Billions

$ 19,815,420,000.00

Total Shares Outstanding

437.00 Millions

437,000,000

Average Daily Trading Volume

$ 3.66 Millions

$ 3,655,910.00

Sector

Financial

Industry

Auxiliary Activities of Financial Services

RPRX

revenue by Business Segment Royalty Pharma

Revenue by Region Royalty Pharma

RPRX revenue and profits

Financial Results RPRX

DRAG THE FRAME TO SEE MORE DATA

RPRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BRK-A - Berkshire Hathaway

$ 733,550.00 --0,92% (12M)

P/E

10.12

0.00%

ROE

9.94%

P/BV

1.01

BRK-B - Berkshire Hathaway

$ 488.13 --1,09% (12M)

P/E

14.53

0.00%

ROE

9.94%

P/BV

1.44

JPM - JPMorgan

$ 312.37 20,44% (12M)

P/E

14.34

1.90%

ROE

16.18%

P/BV

2.32

SNEX - StoneX Group

$ 115.54 103,51% (12M)

P/E

18.99

0.00%

ROE

17.13%

P/BV

3.25

MS - Morgan Stanley

$ 211.93 64,66% (12M)

P/E

19.04

1.89%

ROE

15.51%

P/BV

2.95

BAC - Bank of America

$ 53.83 23,05% (12M)

P/E

12.32

2.04%

ROE

10.54%

P/BV

1.30

C - Citigroup

$ 132.47 73,32% (12M)

P/E

14.36

1.81%

ROE

7.54%

P/BV

1.08

PGR - Progressive

$ 204.02 --22,22% (12M)

P/E

10.34

6.81%

ROE

36.08%

P/BV

3.73

BRK-A - Berkshire Hathaway

$ 733,550.00 --0,92% (12 M)

P/L

10.12

0.00%

ROE

9.94%

P/VP

1.01

BRK-B - Berkshire Hathaway

$ 488.13 --1,09% (12 M)

P/L

14.53

0.00%

ROE

9.94%

P/VP

1.44

JPM - JPMorgan

$ 312.37 20,44% (12 M)

P/L

14.34

1.90%

ROE

16.18%

P/VP

2.32

SNEX - StoneX Group

$ 115.54 103,51% (12 M)

P/L

18.99

0.00%

ROE

17.13%

P/VP

3.25

MS - Morgan Stanley

$ 211.93 64,66% (12 M)

P/L

19.04

1.89%

ROE

15.51%

P/VP

2.95

BAC - Bank of America

$ 53.83 23,05% (12 M)

P/L

12.32

2.04%

ROE

10.54%

P/VP

1.30

C - Citigroup

$ 132.47 73,32% (12 M)

P/L

14.36

1.81%

ROE

7.54%

P/VP

1.08

PGR - Progressive

$ 204.02 --22,22% (12 M)

P/L

10.34

6.81%

ROE

36.08%

P/VP

3.73

Frequently Asked Questions

What is the price of Royalty Pharma (RPRX) today?

The current price of Royalty Pharma (RPRX) is $ 55.87, representing a 70.15% gain over the past year. The stock began the year trading around $ 38.64 and is currently priced at $ 55.87. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Royalty Pharma (RPRX) pay dividends?

In the last year, Royalty Pharma (RPRX) distributed dividends in the month of March, totaling $ 0.24. The Dividend Yield for the last 12 months is 1.60%.

Is Royalty Pharma (RPRX) a good investment?

Royalty Pharma (RPRX) is currently trading at $ 55.87 with a P/E ratio of 29.51. This represents a 8,924% premium compared to its historical average P/E. Over the past year, the stock has gained 70.15 and paid $ 0.24 in dividends, resulting in a dividend yield of 1.60%. The total shareholder return over the same period was 70.15%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Royalty Pharma (RPRX) stock?

You can buy Royalty Pharma (RPRX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol RPRX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Royalty Pharma (RPRX) yield today?

Over the past month, Royalty Pharma (RPRX) has returned 11.29% — 70.15% over the past year, and 35.96% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.90 per share in dividends, resulting in a dividend yield of 1.60%.

If you were to purchase 100 shares of Royalty Pharma (RPRX) today at the current price of $ 55.87 your total investment would be $ 5,587.00.

Based on historical performance, the investment would have grown to approximately:

$ 9,506.28 after 1 year
$ 7,596.09 after 5 years
$ 5,587.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

RPRX

Royalty Pharma PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment RPRX

review the fundamentals of Royalty Pharma shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 1.60%

5-year average DY: 2.51%

type

Ex - Dividend Date

payment date

value

ABOUT Royalty Pharma

Royalty Pharma PLC

United States

6 years

2020

-

PROFIT X PRICE RPRX

Financial Results RPRX

RPRX cash flow

Asset, Revenue and Profit Growth - RPRX

RPRX balance sheet

BRK-A - Berkshire Hathaway

BRK-B - Berkshire Hathaway

JPM - JPMorgan

SNEX - StoneX Group

MS - Morgan Stanley

BAC - Bank of America

C - Citigroup

PGR - Progressive

BRK-A - Berkshire Hathaway

BRK-B - Berkshire Hathaway

JPM - JPMorgan

SNEX - StoneX Group

MS - Morgan Stanley

BAC - Bank of America

C - Citigroup

PGR - Progressive

Frequently Asked Questions